Top Markets
Coin of the day
Atrion Corporation Atrion Corporation

Atrion Corporation

ATRI
Pozycja w akcjach #38752
Atrion Corporation, along with its affiliated entities, specializes in the... Atrion Corporation, along with its affiliated entities, specializes in the development, production, and global distribution of medical devices for fluid management, cardiovascular health, and ophthalmology, reaching markets across the United States, Canada, Europe, and beyond. Its fluid management portfolio includes valves designed to precisely regulate the flow of liquids or gases, vital for various intubation, intravenous, and catheter applications in anesthesia and oncology, and instrumental in promoting infection control in both hospital and home healthcare environments. In the cardiovascular segment, the company offers a Myocardial Protection System that delivers essential fluids and medications, accurately mixes critical drugs, and meticulously controls variables such as temperature and pressure. This division also provides vacuum relief valves for cardiac surgeries, silicone vessel loops used for retracting and occluding blood vessels, and inflation devices crucial for balloon catheter expansion, stent placement, and fluid delivery, along with other products for heart bypass procedures. For ophthalmology, Atrion supplies specialized medical apparatus for sterilizing contact lenses and a range of balloon catheters employed to treat nasolacrimal duct obstructions in pediatric and adult patients. Beyond these core areas, the corporation also manufactures instruments and corresponding single-use items for assessing the activated clotting time of blood, and secure containment solutions for needles and scalpel blades. Furthermore, Atrion fabricates inflation mechanisms and valves for maritime and aerospace safety equipment, essential components for inflatable survival gear and structures, and both unidirectional and bidirectional pressure relief valves. These valves are crucial for safeguarding delicate electronics and various other goods during transit, serving both medical and non-medical contexts. Atrion distributes its comprehensive suite of products to a diverse client base, including medical practitioners, hospitals, clinics, other care facilities, and fellow equipment manufacturers. This distribution is managed through a multi-channel approach, utilizing a dedicated direct sales team, independent representatives, and a broad network of distributors. Established in 1944, Atrion Corporation maintains its primary operational base in Allen, Texas.
Cena akcji
$0.45992
Ostatnia synchronizacja: 2024-08-30
Kapitalizacja rynkowa
$821.42K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
US
Handel Atrion Corporation (ATRI)

Kategoria

Wskaźnik P/E dla Atrion Corporation (ATRI)
Wskaźnik P/E na dzień August 2026 TTM: 41.74
Według najnowszych raportów finansowych i ceny akcji Atrion Corporation, obecny wskaźnik P/E (TTM) wynosi 41.74. Na koniec 2022 wskaźnik P/E wynosił 28.56.
Historia wskaźnika P/E dla Atrion Corporation od 2000 do 2026
Wskaźnik P/E na koniec każdego roku
Rok Wskaźnik P/E Zmień
2026 (TTM) 41.74 21.46%
2023 34.36 20.33%
2022 28.56 -26.18%
2021 38.68 5.36%
2020 36.72 -3.18%
2019 37.92 -5.40%
2018 40.09 26.02%
2017 31.81 -5.16%
2016 33.54 37.87%
2015 24.33 1.62%
2014 23.94 6.87%
2013 22.40 33.96%
2012 16.72 -10.23%
2011 18.63 7.77%
2010 17.28 -5.53%
2009 18.30 50.54%
2008 12.15 -27.83%
2007 16.84 25.99%
2006 13.37 -3.87%
2005 13.90 13.98%
2004 12.20 -17.96%
2002 14.87 87.49%
2001 7.93 -26.66%
2000 10.81 0.00%
Wskaźnik P/E dla podobnych firm lub konkurentów
Firma Wskaźnik P/E Różnica wskaźnika P/E Kraj
39.92 -4.34%
US
30.38 -27.21%
FR
- -
JP
41.93 0.47%
US
- -
CH
Jak odczytywać wskaźnik P/E?

Wskaźnik Cena/Zysk (P/E) mierzy relację między ceną akcji firmy a jej zyskiem na akcję.
Niski, ale dodatni P/E oznacza firmę osiągającą wysokie zyski względem obecnej wyceny i może być niedowartościowana. Wysoki ujemny (bliski 0) P/E wskazuje na duże straty.

Firmy z P/E powyżej 30 lub ujemnym uznaje się zazwyczaj za "akcje wzrostowe", czyli inwestorzy oczekują wzrostu lub przyszłych zysków.

Firmy z dodatnim P/E poniżej 10 uznaje się za "akcje wartościowe", co oznacza, że są już bardzo dochodowe, ale bez dużego potencjału wzrostu.